Literature DB >> 9526956

Myths and realities of P-selectin plasma levels in patients with acute myocardial infarction.

P A Gurbel, V L Serebruany.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9526956     DOI： 10.1016/s0049-3848(97)00263-6

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  4 in total

1.  Usefulness of combining necrosis and platelet markers in triaging patients presenting with chest pain to the emergency department.

Authors:  V L Serebruany; D J Levine; G V Nair; A F Meister; P A Gurbel
Journal:  J Thromb Thrombolysis       Date:  2001-04       Impact factor: 2.300

2.  Effect of coronary thrombolysis on the plasma concentration of osteonectin (SPARC, BM40) in patients with acute myocardial infarction.

Authors:  V L Serebruany; D Atar; S R Murugesan; S Jerome; H Semaan; P A Gurbel
Journal:  J Thromb Thrombolysis       Date:  2000-10       Impact factor: 2.300

3.  Soluble P-selectin is not a surrogate marker for platelet P-selectin: evidence from a multicenter chest pain study group.

Authors:  P A Gurbel; D J Kereiakes; V L Serebruany
Journal:  J Thromb Thrombolysis       Date:  2000-08       Impact factor: 2.300

4.  Serum levels of soluble P-selectin are increased and associated with disease activity in patients with Behçet's syndrome.

Authors:  Yusuf Turkoz; Cem Evereklioglu; Abdullah Ozkiriş; Selçuk Mistik; Murat Borlu; Ibrahim H Ozerol; Fuat Duygulu; Ozgür Ilhan
Journal:  Mediators Inflamm       Date:  2005-08-31       Impact factor: 4.711
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.